Sort
130,381 grants matching “hiv”
University of Cincinnati AIDS Clinical Trials Unit- UC ACTU
$1,668,393Carl J Fichtenbaum · University Of Cincinnati · UM1 · FY2012 · AI
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, Zika and Japanese Encephalitis Virus vaccines
$1,668,139Jay Nelson · Oregon Health & Science University · N01 · FY2018 · AI
PS10-1001, HIV PREVENTION PROJECTS
$1,668,049Loretta Emily Haddy · West Virginia State Dept Hlth/Human Rscs · U62 · FY2010 · PS
SUPPORT THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE AND
$1,667,917Aabid Ahmed · Mkomani Clinic Society · U2G · FY2013 · PS
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$1,667,791Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Integrated University of Puerto Rico Clinical Trials Unit
$1,667,675Carmen D Zorrilla · University Of Puerto Rico Med Sciences · UM1 · FY2014 · AI
Imaging Studies in Neurotoxicity and Neurodevelopment
$1,667,631Linda Chang · University Of Hawaii At Manoa · U54 · FY2009 · NS
Immunologic control of HIV-1 through combination bNAbs and biologics.
$1,667,616Marina Caskey · Rockefeller University · U01 · FY2022 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,667,113New York University School Of Medicine · U01 · FY2003 · AI
Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC)
$1,667,046Mai Tuyet Pho · University Of Chicago · UH3 · FY2021 · DA
REDUCE THE IMPACT OF HIV IN SO SUDAN, UNDER PRES EMERG PLAN F/AIDS RELIEF
$1,666,000Karen Blyth · Intrahealth International, Inc. · U62 · FY2008 · PS
Structure-Function Studies of the HIV-1 Envelope Glycoproteins
$1,665,552Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations
$1,665,551Aaron Weinberg · Case Western Reserve University · P01 · FY2010 · DE
Imaging Studies in Neurotoxicity and Neurodevelopment
$1,665,443Linda Chang · University Of Hawaii At Manoa · U54 · FY2008 · NS
Emory/Atlanta Center for AIDS Research
$1,665,424James W. Curran · Emory University · P30 · FY2008 · AI
Development of a Vaccine for HIV-AIDS: Humoral Immunity
$1,664,829Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
PS04-012, HIV PREVENTION PROJECTS
$1,664,263Mary J Jones · Iowa State Dept Of Public Health · U62 · FY2008 · PS
Noncoding RNA structures and interactions in cellular stress responses
$1,664,224Jinwei Zhang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Pathogenesis and Treatment of HIV Infection
$1,664,106H. Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Multilevel Influences on HIV and Substance use in a YMSM Cohort
$1,664,058Brian Mustanski · Northwestern University At Chicago · U01 · FY2015 · DA
National Resource For Advanced NMR Technology
$1,663,854Timothy A Cross · Florida State University · P41 · FY2017 · GM
Imaging Studies in Neurotoxicity and Neurodevelopment
$1,663,826Linda Chang · University Of Hawaii At Manoa · U54 · FY2011 · NS
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
$1,663,314Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
HIV VACCINE CLINICAL TRIAL UNIT AT SAINT LOUIS UNIVER
$1,663,021Saint Louis University · U01 · FY2001 · AI
Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC)
$1,662,862Mai Tuyet Pho · University Of Chicago · UH3 · FY2020 · DA